Not Yet Recruiting INTERVENTIONAL NCT07555769

Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial (CALCIFER)

Calcium Electroporation for Urinary Bladder Tumors: A First-in-human Feasibility, Safety, and Early Response Trial - The CALCIFER Trial

Sponsor: Juan Luis Vásquez

Conditions Bladder Tumor Bladder Tumors Urothelial Carcinoma (UC) Urothelial Carcinoma Bladder

Interventions Calcium electroporation Intratumoral calcium injection Transurethral electroporation

Updated 1 time since 2026 Last updated: Apr 21, 2026 Started: Jun 1, 2026 Primary completion: Apr 1, 2030 Completion: Apr 1, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07555769, this observational or N/A phase trial focuses on Bladder Tumor and Bladder Tumors and remains actively recruiting participants. Sponsored by Juan Luis Vásquez, it has been updated 1 time since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [daily]

Eligibility Summary

This phase I study evaluates intravesical calcium electroporation (CaEP) with a new transurethral electrode. The study is primarily designed to assess the safety of CaEP and secondarily, to preliminary explore the efficacy in patients with limited alternative therapies. The anticipated benefits and structured safety precautions justify the ethical conduct of the investigation.

Contact Information

Sponsor contact:

Juan Luis Vásquez

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.